Glenn has made over 1 trades of the Sorrento Therapeutics Inc stock since 2014, according to the Form 4 filled with the SEC. Most recently Glenn exercised 1,194,900 units of SRNE stock worth $394,317 on 21 February 2014.
The largest trade Glenn's ever made was exercising 1,194,900 units of Sorrento Therapeutics Inc stock on 21 February 2014 worth over $394,317. On average, Glenn trades about 79,660 units every 0 days since 2008. As of 21 February 2014 Glenn still owns at least 1,194,900 units of Sorrento Therapeutics Inc stock.
You can see the complete history of Glenn Halpryn stock trades at the bottom of the page.
Glenn's mailing address filed with the SEC is 6042 CORNERSTONE CT. WEST, SUITE B, SAN DIEGO, CA, 92121.
Over the last 15 years, insiders at Sorrento Therapeutics Inc have traded over $17,198,839 worth of Sorrento Therapeutics Inc stock and bought 10,353,437 units worth $10,703,222 . The most active insiders traders include Jane Ph D Hsiao, Edgar Lee и Patrick Chan Soon Shiong Fa.... On average, Sorrento Therapeutics Inc executives and independent directors trade stock every 60 days with the average trade being worth of $2,947. The most recent stock trade was executed by Henry Ji on 7 September 2022, trading 88,888 units of SRNE stock currently worth $179,554.
sorrento therapeutics is an antibody-centric, clinical stage biopharmaceutical company developing new treatments for cancer, inflammation and autoimmune diseases. sorrento's lead products are multiple late-stage biosimilar and biobetter antibodies, as well as clinical car-t therapies targeting solid tumors.
Sorrento Therapeutics Inc executives and other stock owners filed with the SEC include: